McKesson | MCK - Beneficio Bruto En Ventas

Precio De Mercado
815.20
Cambio Diario
-7.43 -0.90%
Mensual
-5.80%
Anual
15.34%
Q2 Expectativa
810.39




Beneficio Bruto En Ventas Cambio Fecha
Acadia Healthcare USD 790.7M 30.46M 2025-12
Align Technology USD 736.59M 53M 2026-03
Cardinal Health USD 2.5B 101M 2026-03
Centene USD 5.26B 3.12B 2026-03
Charles River Laboratories USD 271.96M 39.43M 2025-12
Cigna USD 56.45B 50.29B 2025-09
Community Health Systems USD 2.76B 70M 2024-12
Computer Programs Systems USD 35.62M 3.23M 2025-12
CVS Health USD 13.57B 239M 2025-12
DaVita Healthcare Partners USD 1.02B 63.9M 2025-12
Dentsply International USD 443M 2M 2025-12
eHealth USD -42.47M 14.5M 2024-09
Elevance Health USD 11.68B 889M 2025-12
Encompass Health USD 1.48B 67.2M 2025-12
HCA USD 8.18B 161M 2025-12
Henry Schein USD 1.06B 37M 2025-12
Humana USD 4.82B 754M 2025-06
IQVIA Holdings USD 1.12B 32M 2025-12
J&J USD 17.24B 642M 2026-03
Laboratory Of America USD 993.2M 31.9M 2025-12
McKesson USD 3.68B 143M 2025-12
Molina Healthcare USD 1.49B 292M 2026-03
Owens Minor USD 272.05M 20.92M 2025-12
Quest Diagnostics USD 906M 33M 2026-03
Stryker USD 4.49B 633M 2025-12
Tenet Healthcare USD 4.52B 2.3B 2025-12
UnitedHealth USD 18.49B 2.14B 2025-12
Universal Health Services USD 4.06B 2.05B 2025-12
Veradigm USD 83.44M 3.95M 2022-09